Private company
Manulife Private Credit Fund
Manulife Private Credit Fund is an investment fund based in Boston, United States.1
Last updated Oct 20, 2026.
Overview
- HeadquartersBoston, Massachusetts1
- Incorporated inDE2
- Business address197 Clarendon Street, Boston, Ma 021162
- Filer category, Emerging growth company2
- Legal formOther
- Kind of organizationInvestment fund1
See how the biggest companies compare on our leaderboards
Manulife Private Credit Fund was formed on February 8, 2023, as a Delaware statutory trust, and commenced operations on July 17, 2023. We are an externally managed, diversified closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), on October 3, 2023 (the date of the Fund’s election to be regulated as a BDC under the 1940 Act is referred to herein as the “BDC Election Date”). In addition, we have elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), and intend to maintain our qualification as a RIC annually thereafter.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Corporate structure
Manulife Private Credit Fund sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Manulife Private Credit Fund
- Manufacturers Life Reinsurance Ltd Filed SCHEDULE 13G/A on Manulife Private Credit Fund, latest May 7, 2025 (3 filings since Nov 8, 2023)
- Manulife (International) Ltd Filed SCHEDULE 13G/A on Manulife Private Credit Fund, latest May 7, 2025 (3 filings since Nov 8, 2023)
- Manulife Private Credit Fund Boston, Massachusetts
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Manulife Private Credit Fund reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Properties, in its own words
We do not own any real estate or other physical properties materially important to our operation or any of our subsidiaries. Our headquarters are currently located at 197 Clarendon Street, Boston, MA 02116, where we occupy office space pursuant to the Service Agreement. We believe that our office facilities are suitable and adequate for our business as it is contemplated to be conducted.
Item 2 of the 10-K filed Feb 25, 2026.3
Leadership
Who has led Manulife Private Credit Fund, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
- Chief financial officerHeidi Knapp Sep 13, 2023 to Sep 13, 20238
Board members and other officers (12)
- Chief Compliance OfficerMercy Bishay Jan 16, 2026 to now9
- Vice PresidentWilliam D. Droege Apr 29, 2024 to Apr 29, 202410
- Vice PresidentBlake Witherington Sep 13, 2023 to Sep 13, 202311
- Chief Compliance OfficerJason M. Pratt Sep 13, 2023 to Sep 13, 202312
- Vice President, CMLWilliam T. Shields Sep 13, 2023 to Sep 13, 202313
- Chief Compliance OfficerBrian Vandelinder Oct 16, 2023 to Oct 16, 202314
- Board memberGrace K. Fey Sep 13, 2023 to Sep 13, 202315
- Board memberHassell H. McClellan Sep 13, 2023 to Sep 13, 202316
- Board memberIan R. Roke Sep 13, 2023 to Sep 13, 202317
- Board memberDeborah C. Jackson Sep 14, 2023 to Sep 14, 202318
- General counselChristopher Sechler Apr 29, 2024 to Apr 29, 202419
- General counselEphraim David Pemstein Sep 13, 2023 to Sep 13, 202320
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Vice President, Senior LoansMichael Michael King named Oct 17, 202521
Timeline
- Sep 30, 20268-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale22
- Sep 25, 20268-K Shareholder vote23
- Jul 1, 20268-K Other events24
- Jun 23, 20268-K Entered a material agreement25
- Apr 2, 20268-K Other events26
- Jan 20, 20268-K Other events27
- Dec 18, 20258-K Executive or director change28
- Nov 20, 20258-K Shareholder vote; Other events29
- Oct 14, 20258-K Entered a material agreement; New debt or obligation30
- Sep 30, 20258-K Other events31
- Aug 1, 20258-K Executive or director change32
- Jun 30, 20258-K Other events33
Filings
91 filings to the SEC since October 2021: 3 annual reports, 8 quarterly reports, 25 major events, 29 insider forms, 11 large holders, 3 private raises, 12 other. The latest 20:
- Sep 30, 202615-12G EDGAR
- Sep 30, 2026N-54C EDGAR
- Sep 30, 20268-K EDGAR
- Sep 25, 20268-K EDGAR
- Aug 13, 202610-Q EDGAR
- Jul 1, 20268-K EDGAR
- Jun 23, 2026425 EDGAR
- Jun 23, 20268-K EDGAR
- Jun 12, 202640-17G/A MANULIFE PRIVATE CREDIT FUND EDGAR
- May 13, 202640-17G MANULIFE PRIVATE CREDIT FUND EDGAR
- May 12, 202610-Q EDGAR
- Apr 2, 20268-K EDGAR
- Feb 25, 202610-K EDGAR
- Jan 20, 20268-K EDGAR
- Jan 16, 20263 PRIMARY DOCUMENT EDGAR
- Dec 18, 20258-K EDGAR
- Nov 20, 20258-K EDGAR
- Nov 12, 202510-Q EDGAR
- Nov 6, 2025DEF 14A MANULIFE PRIVATE CREDIT FUND EDGAR
- Oct 24, 2025PRE 14A MANULIFE PRIVATE CREDIT FUND EDGAR
The 91 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
12 open-market trades by officers, directors and large owners since October 2021: 12 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 30, 2025 | Manulife Private Credit Plus Fund10% owner | Buy | 728,633 | $20.59 | $15.0M | Form 4 |
| Jun 2, 2025 | Manulife Private Credit Plus Fund10% owner | Buy | 728,633 | $20.59 | $15.0M | Form 4 |
| May 30, 2025 | Manulife Private Credit Plus Fund10% owner | Buy | 1,451,098 | $20.67 | $30.0M | Form 4 |
| May 1, 2025 | Manulife Private Credit Plus Fund10% owner | Buy | 1,435,132 | $20.90 | $30.0M | Form 4 |
| Feb 3, 2025 | Manulife Private Credit Plus Fund10% owner | Buy | 720,195 | $20.83 | $15.0M | Form 4 |
| Mar 1, 2024 | Manulife Private Credit Plus Fund10% owner | Buy | 718,391 | $20.88 | $15.0M | Form 4 |
| Jan 31, 2024 | Manulife Private Credit Plus Fund10% owner | Buy | 723,237 | $20.74 | $15.0M | Form 4 |
| Jan 31, 2024 | Manulife Private Credit Plus Fund10% owner | Buy | 723,237 | $20.74 | $15.0M | Form 4 |
| Jan 2, 2024 | Manulife Private Credit Plus Fund10% owner | Buy | 713,946 | $21.01 | $15.0M | Form 4 |
| Jan 2, 2024 | Manulife Private Credit Plus Fund10% owner | Buy | 713,946 | $21.01 | $15.0M | Form 4 |
| Nov 1, 2023 | Manulife (International) Ltd10% owner | Buy | 295,427 | $20.74 | $6.1M | Form 4 |
| Nov 1, 2023 | Manufacturers Life Reinsurance Ltd10% owner | Buy | 126,612 | $20.74 | $2.6M | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Manufacturers Life Reinsurance LtdSCHEDULE 13G/A, 3 filings Nov 8, 2023 to May 7, 202534
- Manulife (International) LtdSCHEDULE 13G/A, 3 filings Nov 8, 2023 to May 7, 202535
Money raised
Private offerings the company reported to the SEC on Form D.
- Nov 1, 2023Raised $128.8 million in a private offering of equity Form D: 3 investors so far Form D
SEC filer profile
How Manulife Private Credit Fund is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARManulife Private Credit Fund1
- CIK0001988280
- Employer ID (EIN)92-39685523
- Filer statusNon-accelerated filer an emerging growth company; not a smaller reporting company; not a shell company3
- Incorporated inDelaware3
- Fiscal year endsDecember 311
- Business address197 Clarendon Street, Boston, MA 021161
- Phone617-663-30001
- Shares outstanding8,256,380 as of Aug 13, 20266
- Public float$0 as of Dec 31, 20254
- AuditorErnst & Young, Boston, Massachusetts PCAOB ID 42; no auditor attestation of internal control over financial reporting3
- On EDGAR sinceAug 4, 20231
- Filings98 in all: 8-K (25), 3 (16), 4 (9), 10-Q (8), SC 13G (7), 40-17G (4), 10-K (3), 4/A (3)1
All 25 form types
40-APP/A (3), 40-17G/A (2), D/A (2), SCHEDULE 13G (2), SCHEDULE 13G/A (2), 10-12G (1), 10-12G/A (1), 15-12G (1), 3/A (1), 40-APP (1), 425 (1), CORRESP (1), D (1), DEF 14A (1), N-54A (1), N-54C (1), PRE 14A (1)
- Latest filingsAnnual report (10-K) Feb 25, 2026
Quarterly report (10-Q) Aug 13, 2026
Proxy statement (DEF 14A) Nov 6, 2025
Latest 8-K (8-K) Sep 30, 2026
Risk factors and legal proceedings
The risks Manulife Private Credit Fund names in Item 1A of its 10-K filed Feb 25, 2026: 49 risks under these headings, as written.3
- Risks Related to Our Business and Structure
- We are a relatively new company and have a limited operating history.
- Our Board of Trustees has broad authority.
- Our Board of Trustees may amend our Declaration of Trust without prior shareholder approval.
- Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation.
- Our ability to achieve our investment objectives depends on the Advisor’s ability to manage and support our investment process and if the Investment Advisory Agreement were to be terminated, or if the Advisor loses any members of its senior management team, our ability to achieve our investment objectives could be significantly harmed.
- Any failure by the Advisor to manage and support our investment process may hinder the achievement of our investment objectives.
- Because our business model depends to a significant extent upon relationships with private equity sponsors, investment banks and commercial banks, the inability of the Advisor to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.
- We operate in a highly competitive market for investment opportunities, which could reduce returns and result in losses.
- As required by the 1940 Act, a significant portion of our investment portfolio is and will be recorded at fair value as determined in good faith and, as a result, there is and will be uncertainty as to the value of our portfolio investments.
- There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time.
- We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from the Private Offering, to fund distributions (which may reduce the amount of capital we ultimately invest in assets).
The other 38 risks
- Although we expect to adopt a share repurchase program, we have discretion to not repurchase your shares or to suspend the program.
- The timing of our repurchase offers pursuant to our share repurchase program may be at a time that is disadvantageous to our shareholders.
- The price at which we may repurchase Common Shares pursuant to our share repurchase program will be determined in accordance with the Advisor’s valuation policy and, as a result, there may be uncertainty as to the value of our Common Shares.
- It may be difficult to bring suit or foreclosure in non-U.S. countries.
- Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution.
- We may not be able to obtain all required state licenses.
- Legislative or other actions relating to taxes could have a negative effect.
- The Fund and its portfolio companies may be subjected to potential adverse effects of new or modified laws or regulations.
- Compliance with the SEC’s Regulation Best Interest may negatively impact our ability to raise capital in the Private Offering, which would harm our ability to achieve our investment objectives.
- Our Declaration of Trust includes exclusive forum and jury trial waiver provisions that could limit a shareholder’s ability to bring a claim, make it more expensive or inconvenient for a shareholder to bring a claim, or, if such provisions are deemed inapplicable or unenforceable by a court, cause the Fund to incur additional costs associated with such action.
- Risks Related to Our Investments
- Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment.
- International investments create additional risks.
- Investing in middle-market companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results.
- A lack of liquidity in certain of our investments may adversely affect our business.
- Risks Related to the Advisor and Its Affiliates; Conflicts of Interest
- We may be obligated to pay the Advisor incentive compensation on income that we have not received.
- We may be obligated to pay the Advisor incentive compensation even if we incur a net loss due to a decline in the value of our portfolio.
- Our shares may be purchased by the Advisor or its affiliates.
- The Placement Agent’s influence on the Private Offering gives it the ability to increase the fees payable to the Advisor.
- Risks Related to Business Development Companies
- Failure to maintain our status as a BDC would reduce our operating flexibility.
- We are uncertain of our future sources for funding our future capital needs and if we cannot obtain debt or equity financing on acceptable terms, or at all, our ability to acquire investments and to expand our operations will be adversely affected.
- The requirement that we invest a sufficient portion of our assets in qualifying assets could preclude us from investing in accordance with our current business strategy; conversely, the failure to invest a sufficient portion of our assets in qualifying assets could result in our failure to maintain our status as a BDC.
- Regulations governing our operation as a BDC and a RIC will affect our ability to raise, and the way in which we raise, additional capital or borrow for investment purposes, which may have a negative effect on our growth.
- Our ability to enter into transactions with our affiliates is restricted.
- We are a diversified investment company within the meaning of the 1940 Act, and therefore we are limited with respect to the proportion of our assets that may be invested in securities of a single issuer.
- Risks Related to Debt Financing
- We may default under our credit facilities.
- Provisions in a credit facility may limit our investment discretion.
- Changes in interest rates may affect our cost of capital and net investment income.
- Tariffs may adversely affect us or our portfolio companies.
- We may form one or more CLOs, which may subject us to certain structured financing risks.
- Federal Income Tax and Related Risk
- Risks Related to an Investment in the Common Shares
- We face risks associated with the deployment of our capital.
- We may have difficulty sourcing investment opportunities.
- We may have difficulty paying distributions and the tax character of any distributions is uncertain.
- Certain investors will be subject to Exchange Act filing requirements.
- Shareholders may experience dilution.
- Any Preferred Shares we may determine to issue in the future could adversely affect the value of the Common Shares.
- Holders of any Preferred Shares that we may issue will have the right to elect certain members of our Board of Trustees and have class voting rights on certain matters.
- General Risk Factors
- As an SEC-reporting company, we are subject to regulations not applicable to private companies, such as provisions of the Sarbanes-Oxley Act. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us.
- We are an “emerging growth company” under the JOBS Act, and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our shares less attractive to investors.
Legal proceedings
There are no legal proceedings to which the Fund or the Advisor is a party that are likely to have a material adverse effect on the Fund or the ability of the Advisor to perform its services under the Investment Advisory Agreement with the Fund, nor, to our knowledge, is any material legal proceeding threatened against us or the Advisor.
The opening of Item 3, Legal Proceedings.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARHeidi Knapp, Chief financial officer
- 9
- 10SEC EDGARWilliam D. Droege, Vice President
- 11SEC EDGARBlake Witherington, Vice President
- 12
- 13
- 14
- 15SEC EDGARGrace K. Fey, Board member
- 16SEC EDGARHassell H. McClellan, Board member
- 17SEC EDGARIan R. Roke, Board member
- 18SEC EDGARDeborah C. Jackson, Board member
- 19SEC EDGARChristopher Sechler, General counsel
- 20
- 21
- 22
- 23SEC EDGARShareholder vote
- 24SEC EDGAROther events
- 25SEC EDGAREntered a material agreement
- 26SEC EDGAROther events
- 27SEC EDGAROther events
- 28SEC EDGARExecutive or director change
- 29SEC EDGARShareholder vote; Other events
- 30
- 31SEC EDGAROther events
- 32SEC EDGARExecutive or director change
- 33SEC EDGAROther events
- 34
- 35